The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Author(s): Olivia Bibollet-Bahena, Qiao-Ling Cui, Guillermina Almazan

Journal Name: Central Nervous System Agents in Medicinal Chemistry
(Formerly Current Medicinal Chemistry - Central Nervous System Agents)

Volume 9 , Issue 2 , 2009

Become EABM
Become Reviewer


The insulin-like growth factor-1 (IGF-1) is a pleiotropic factor. Many studies have revealed its importance in the development and maintenance of the central nervous system (CNS). This review will discuss the IGF-1 axis, from the factor itself to the signalling pathways it activates, and its tight regulation. Particular focus will be brought on potential therapeutic targets of the IGF-1 axis in CNS disorders, including brain tumours and neurodegenerative diseases affecting neurons and oligodendrocytes.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [95 - 109]
Pages: 15
DOI: 10.2174/187152409788452108
Price: $65

Article Metrics

PDF: 10